Products for Research Use Only
RegisterLogin

CA-4948

CAT: 0931-T9027-04Size: 1 mL - 10 mM (in DMSO)Dry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T9027-04Size:1 mL - 10 mM (in DMSO)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1801344-14-8
Target
FLT, Apoptosis, NF-κB, IRAK, MyD88
Related Pathways
Apoptosis, Tyrosine Kinase/Adaptors, NF-κB, Angiogenesis, Immunology/Inflammation
Purity
0.9988
Bioactivity
CA-4948 (Emavusertib) is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity.
Smiles
Cc1cc(ccn1)-c1nc(co1)C(=O)Nc1cc2oc(nc2nc1N1CC[C@@H](O)C1)N1CCOCC1
Molecular Formula
C24H25N7O5
Molecular Weight
491.5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Emavusertib

Emavusertib is an orally bioavailable, reversible inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4), with potential antineoplastic, immunomodulating and anti-inflammatory activities. Upon oral administration, emavusertib targets, binds to, and blocks the kinase activity of IRAK4. This inhibits IRAK4-mediated signaling, prevents the activation of IRAK4-mediated nuclear factor-kappa B (NF-kB) signaling and decreases the expression of inflammatory cytokines and certain pro-survival factors. This inhibits proliferation of IRAK4-overactivated tumor cells, which are found in cells harboring MYD88 activating mutations or those with overactivated toll-like receptor (TLR) pathways. In addition, emavusertib may inhibit inflammation and immune-mediated cell destruction in inflammatory and auto-immune diseases where TLR or interleukin 1 receptor (IL-1R) signaling is overactivated and MYD88 is dysregulated. IRAK4, a serine/threonine-protein kinase that plays a key role in both the TLR and IL-1R signaling pathways, is activated though the adaptor protein MYD88 and links the TLR and IL-1R signaling pathway to the NF-kB pathway.

CAS Number1801344-14-8
PubChem CID118224491
IUPAC NameN-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide
Molecular FormulaC24H25N7O5
Molecular Weight491.5
XLogP1.7
Topological Polar Surface Area143
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Heavy Atom Count36
Formal Charge0
Complexity773
SMILES
CC1=NC=CC(=C1)C2=NC(=CO2)C(=O)NC3=CC4=C(N=C3N5CC[C@H](C5)O)N=C(O4)N6CCOCC6
InChI
InChI=1S/C24H25N7O5/c1-14-10-15(2-4-25-14)23-27-18(13-35-23)22(33)26-17-11-19-20(28-21(17)31-5-3-16(32)12-31)29-24(36-19)30-6-8-34-9-7-30/h2,4,10-11,13,16,32H,3,5-9,12H2,1H3,(H,26,33)/t16-/m1/s1
InChIKey
SJHNWSAWWOAWJH-MRXNPFEDSA-N
Chemical Structure
2D Structure
2D structure of Emavusertib
CAS: 1801344-14-8
CID: 118224491
Formula: C24H25N7O5
MW: 491.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight491.5
XLogP31.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Exact Mass491.19171692
Monoisotopic Mass491.19171692
Topological Polar Surface Area143 Ų
Heavy Atom Count36
Formal Charge0
Complexity773
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
T5181-01CA-5f
T25200-01CA-IN-5g
T12378L-01CA-170
T200892-01CA-M11
TYD-03274-01CA-CoA
T21509-01CA 074
T86741-01Ir-CA
T21282-01Topanol CA
T89402-01TCP-MP-CA
T62387-01CA IX-IN-1

Alternative Products

CatalogName
MBS3602741-01CA-4948
A17005-50CA-4948 50mg
A17005-5CA-4948 5mg
A17005-25CA-4948 25mg
C14463-5mgEmavusertib (CA-4948)
A17005-10CA-4948 10mg
A17005-2CA-4948 2mg
A17005-100CA-4948 100mg
A17005-1CA-4948 1mg
A17005-10mM-DCA-4948 10mM * 1mL in DMSO

Popular Products